Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Secretory calcium-binding phosphoprotein proline-glutamine rich 1 (SCPPPQ1) is a small, secreted protein localized in the basal lamina of the cell-tooth interface, particularly in tooth and junctional epithelial tissues[2][6]. It is highly conserved, proline- and glutamine-rich, and encoded within the secretory calcium-binding phosphoprotein (SCPP) gene cluster[2]. SCPPPQ1 plays a structural role in mediating the attachment of epithelial cells to mineralized tooth surfaces, helping maintain the integrity of the gingival seal that protects against bacterial invasion[2][6]. Notably, SCPPPQ1 shows resistance to bacterial degradation and exhibits antimicrobial properties, acting bactericidally against oral pathogens such as *Porphyromonas gingivalis* without being toxic to mammalian cells[1]. There is no direct evidence it is a therapeutic target, drug target, or biomarker in clinical development, but its unique properties indicate a role in oral health and as a component of the extracellular matrix[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Secretory calcium-binding phosphoprotein proline-glutamine rich 1 (SCPPPQ1).